Crystalline forms

Industry

CPC
C07B2200/13

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07BGENERAL METHODS OF ORGANIC CHEMISTRY APPARATUS THEREFOR C07B2200/00Indexing scheme relating to specific properties of organic compounds

Current Industry

C07B2200/13Crystalline forms

Industries

Patents Grantslast 30 patents

Information Patent Grant
Crystalline forms of diazabicyclooctane derivative and production p...
- Patent number 12,221,443
- Issue date Feb 11, 2025
- Meiji Seika Pharma Co., Ltd.
- Takao Abe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and amino e...
- Patent number 12,221,445
- Issue date Feb 11, 2025
- Merck Patent GmbH
- Rudolf Moser
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleu...
- Patent number 12,221,446
- Issue date Feb 11, 2025
- Rudolf Moser
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nε-long chain acyl lysine crystal production method and composition...
- Patent number 12,221,403
- Issue date Feb 11, 2025
- Ajinomoto Co., Inc.
- Shuvendu Biswas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the preparation of trametinib acetic acid solvate
- Patent number 12,221,440
- Issue date Feb 11, 2025
- Aurobindo Pharma Ltd.
- Gangadhara Bhima Shankar Nangi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cholinesterase inhibitor polymorph and application thereof
- Patent number 12,215,085
- Issue date Feb 4, 2025
- CHANGCHUN HUAYUAN HIGH-SCIENCE AND TECHNOLOGY CO., LTD.
- Tonghui Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystal of pyrazolo[3,4-d]pyrimidine
- Patent number 12,215,109
- Issue date Feb 4, 2025
- Taiho Pharmaceutical Co., Ltd.
- Tadashi Shimamura
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-b...
- Patent number 12,215,083
- Issue date Feb 4, 2025
- ATNX SPV, LLC
- Michael P. Smolinski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solid forms of 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{...
- Patent number 12,215,094
- Issue date Feb 4, 2025
- Celgene Corporation
- Eric A. Fromme
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid form, crystalline form, and crystal form a of FXR agonist, an...
- Patent number 12,215,098
- Issue date Feb 4, 2025
- CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
- Xiaolin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glucagon receptor antagonists
- Patent number 12,208,071
- Issue date Jan 28, 2025
- Ligand Pharmaceuticals Incorporated
- Lin Zhi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms of carbazole inhibitors of RhoGTPase for the trea...
- Patent number 12,209,078
- Issue date Jan 28, 2025
- MBQ Pharma
- Jocelyn M. Jiménez Cruz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polymorphic forms of kinase inhibitor compound, pharmaceutical comp...
- Patent number 12,209,080
- Issue date Jan 28, 2025
- EQUINOX SCIENCES, LLC
- Congxin Liang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitor
- Patent number 12,209,073
- Issue date Jan 28, 2025
- KIORA PHARMACEUTICALS GMBH
- Stefan Sperl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of tenofovir alafenamide
- Patent number 12,202,849
- Issue date Jan 21, 2025
- Gilead Sciences, Inc.
- Chiajen Lai
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Addition salt of S1P1 receptor agonist and crystal form thereof, an...
- Patent number 12,202,822
- Issue date Jan 21, 2025
- SuZhou Connect Biopharmaceuticals, Inc.
- Wei Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solid state forms of oclacitinib maleate
- Patent number 12,202,834
- Issue date Jan 21, 2025
- VationPharma B.V.
- Bin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
FeAZD, NiAZD, and CuAZD complexes incorporating 1-(2-hydroxyphenyla...
- Patent number 12,202,846
- Issue date Jan 21, 2025
- KING FAISAL UNIVERSITY
- Mai Mostafa Khalaf Ali
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing 7H-pyrrolo[2,3-d]pyrimidine derivatives and s...
- Patent number 12,195,481
- Issue date Jan 14, 2025
- Japan Tobacco Inc.
- Hiromu Takiguchi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Efficient and scalable syntheses of nicotinoyl ribosides and reduce...
- Patent number 12,195,494
- Issue date Jan 14, 2025
- The Queen's University of Belfast
- Marie Eugenie Migaud
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of the prostacyclin (PGI2) receptor useful for the treat...
- Patent number RE50267
- Issue date Jan 14, 2025
- Arena Pharmaceuticals, Inc.
- Thuy-Anh Tran
Information Patent Grant
Process for the preparation of D,L-methionine
- Patent number 12,195,422
- Issue date Jan 14, 2025
- Evonik Operations GmbH
- Johannes Wefer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polymorphs of integrase inhibitor
- Patent number 12,195,480
- Issue date Jan 14, 2025
- Cipla Limited
- Venkata Srinivas Pullela
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Salt of aldose reductase inhibitor, and preparation method and appl...
- Patent number 12,195,471
- Issue date Jan 14, 2025
- CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
- Zhankun Yang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synthesis method of furoimidazopyridine compound, crystal form of f...
- Patent number 12,195,476
- Issue date Jan 14, 2025
- HANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO., LTD.
- Congxin Liang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lumateperone bis-tosylate salts and crystals and methods for manufa...
- Patent number 12,195,464
- Issue date Jan 14, 2025
- INTRA-CELLULAR THERAPIES, INC.
- Peng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-...
- Patent number 12,187,703
- Issue date Jan 7, 2025
- Novartis AG
- Cornelius Stephen Harlacher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for antagonizing a melanocortin 4 receptor
- Patent number 12,187,727
- Issue date Jan 7, 2025
- Pfizer Inc.
- Christopher Ryan Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Salts of TAM inhibitors
- Patent number 12,187,730
- Issue date Jan 7, 2025
- Incyte Corporation
- Zhongjiang Jia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for resolving optical isomer by using supercritical fluid ex...
- Patent number 12,188,066
- Issue date Jan 7, 2025
- Guang An Mojia Biotechnology Co., Ltd.
- Man Kit Lau
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL

Patents Applicationslast 30 patents

Information Patent Application
Process for Manufacturing Pibrentasvir Active Drug Substance
- Publication number 20250051312
- Publication date Feb 13, 2025
- ABBVIE INC.
- Michael Hillier
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL FEAZD, NIAZD, AND CUAZD COMPLEXES INCORPORATING 1-(2-HYDROXYP...
- Publication number 20250051382
- Publication date Feb 13, 2025
- King Faisal University
- MAI MOSTAFA KHALAF ALI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE EPINEPHRINE MALONATE SALT
- Publication number 20250051262
- Publication date Feb 13, 2025
- Biothea Pharma, Inc.
- Jean-Pierre Sommadossi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TEBIPENEM PIVOXIL CRYSTALLINE FORMS, COMPOSITIONS INCLUDING THE SAM...
- Publication number 20250051334
- Publication date Feb 13, 2025
- SPERO THERAPEUTICS, INC.
- Akash JAIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL FEAZD, NIAZD, AND CUAZD COMPLEXES INCORPORATING 1-(2-HYDROXYP...
- Publication number 20250051383
- Publication date Feb 13, 2025
- King Faisal University
- MAI MOSTAFA KHALAF ALI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF A DEOXYCYTIDINE KINASE INHIBITOR AND USES THEREOF
- Publication number 20250049808
- Publication date Feb 13, 2025
- Trethera Corporation
- David LITZINGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF CFTR MODULATORS
- Publication number 20250051326
- Publication date Feb 13, 2025
- VERTEX PHARMACEUTICALS INCORPORATED
- Yi Shi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALTS OF AN FGFR INHIBITOR
- Publication number 20250051328
- Publication date Feb 13, 2025
- INCYTE CORPORATION
- Zhongjiang Jia
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE BIS-MIPROCIN FUMARATE
- Publication number 20250051280
- Publication date Feb 13, 2025
- CAAMTECH, INC.
- Andrew R. CHADEAYNE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF APOL1 AND METHODS OF USING SAME
- Publication number 20250042878
- Publication date Feb 6, 2025
- VERTEX PHARMACEUTICALS INCORPORATED
- Jingrong CAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Injectable Suspensions
- Publication number 20250041206
- Publication date Feb 6, 2025
- ASARINA PHARMA AB
- Magnus Brisander
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Blarcamesine co-crystals for the manufacture of pharmaceutical dosa...
- Publication number 20250042865
- Publication date Feb 6, 2025
- EGIS GYOGYSZERGYAR ZRT.
- Zsuzsanna SZOKOL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE SALTS OF N-ETHYL-(5-FLUORO-1H-INDOL-3-YL)-N-METHYLETHAN...
- Publication number 20250042851
- Publication date Feb 6, 2025
- Gilgamesh Pharmaceuticals, Inc.
- Andrew Carry Kruegel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PRODUCTION METHOD FOR AROMATIC HYDROXYCARBOXYLIC ACID CRYSTAL
- Publication number 20250042833
- Publication date Feb 6, 2025
- KAO CORPORATION
- Sawa MIZOBATA MIYAKE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTAL FORM OF BLARCAMESINE HYDROCHLORIDE, METHOD FOR PREPARING SA...
- Publication number 20250042866
- Publication date Feb 6, 2025
- Crystal Pharmaceutical (Suzhou) Co., Ltd.
- Yuxing ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALTS FOR MTOR COMPOUNDS
- Publication number 20250042908
- Publication date Feb 6, 2025
- Galderma Holding SA
- Craig Steven HARRIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE SUBSTITUTED PYRAZINES AS PGI2 RECEPTOR AGONISTS
- Publication number 20250034098
- Publication date Jan 30, 2025
- NIPPON SHINYAKU CO., LTD.
- Toshio FUJIWARA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD OF MANUFACTURING A SOLID FORM OF A BET BROMODOMAIN INHIBITOR
- Publication number 20250034142
- Publication date Jan 30, 2025
- ZENITH EPIGENETICS LTD
- FENG WEN
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Application
SALTS AND SOLID FORMS OF A COMPOUND THAT MODULATES IRAK4
- Publication number 20250034154
- Publication date Jan 30, 2025
- GILEAD SCIENCES, INC.
- Stephen E. AMMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-...
- Publication number 20250034157
- Publication date Jan 30, 2025
- ABBVIE INC.
- Ayman Allian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE SALTS OR CO-CRYSTALS OF 2',6-DIFLUORO-5'-[3-(1-HYDROXY-...
- Publication number 20250034155
- Publication date Jan 30, 2025
- NEUROCYCLE THERAPEUTICS, INC.
- Matthew TOCZKO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF (6S,7S)-6-FLUORO-7-(2-FLUORO-5-METHYLPHENYL)-3...
- Publication number 20250034129
- Publication date Jan 30, 2025
- MYOKARDIA, INC.
- Ying YU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYMORPHIC FORMS AND METHODS OF PRODUCING POLYMORPHIC FORMS OF A C...
- Publication number 20250034183
- Publication date Jan 30, 2025
- Viking Therapeutics, Inc.
- Geoffrey E. Barker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COCRYSTALS OF NICOTINAMIDE RIBOSIDE SALTS, CRYSTALLINE FORMS, METHO...
- Publication number 20250026777
- Publication date Jan 23, 2025
- Beiture LLP
- Dedong Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR PREPARING A BENZOATE SALT OF A 1-(3-AMINOPYRROLIDINE-1-...
- Publication number 20250026710
- Publication date Jan 23, 2025
- ASTEX PHARMACEUTICALS, INC.
- Nipun Davar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COCRYSTAL
- Publication number 20250026751
- Publication date Jan 23, 2025
- Takeda Pharmaceutical Company Limited
- Kentaro IWATA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF A PAR4 INHIBITOR
- Publication number 20250026767
- Publication date Jan 23, 2025
- Bristol-Myers Squibb Company
- Roxana F. Schlam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALUMINUM DIETHYLPHOSPHINATE CRYSTAL WITH LOW FINE POWDER CONTENT, P...
- Publication number 20250026771
- Publication date Jan 23, 2025
- JIANGSU LISIDE NEW MATERIAL CO., LTD.
- JINZHONG LI
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Application
FXR (NR1H4) MODULATING COMPOUNDS
- Publication number 20250026744
- Publication date Jan 23, 2025
- GILEAD SCIENCES, INC.
- Peter A. Blomgren
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS OF JAK INHIBITOR AND PROCESS OF PREPARING THE SAME
- Publication number 20250026760
- Publication date Jan 23, 2025
- INCYTE CORPORATION
- Zhongjiang Jia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Crystalline forms

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Crystalline forms of diazabicyclooctane derivative and production p...

Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and amino e...

Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleu...

Nε-long chain acyl lysine crystal production method and composition...

Process for the preparation of trametinib acetic acid solvate

Cholinesterase inhibitor polymorph and application thereof

Crystal of pyrazolo[3,4-d]pyrimidine

Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-b...

Solid forms of 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{...

Solid form, crystalline form, and crystal form a of FXR agonist, an...

Glucagon receptor antagonists

Crystalline forms of carbazole inhibitors of RhoGTPase for the trea...

Polymorphic forms of kinase inhibitor compound, pharmaceutical comp...

Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitor

Crystalline forms of tenofovir alafenamide

Addition salt of S1P1 receptor agonist and crystal form thereof, an...

Solid state forms of oclacitinib maleate

FeAZD, NiAZD, and CuAZD complexes incorporating 1-(2-hydroxyphenyla...

Process for preparing 7H-pyrrolo[2,3-d]pyrimidine derivatives and s...

Efficient and scalable syntheses of nicotinoyl ribosides and reduce...

Modulators of the prostacyclin (PGI2) receptor useful for the treat...

Process for the preparation of D,L-methionine

Polymorphs of integrase inhibitor

Salt of aldose reductase inhibitor, and preparation method and appl...

Synthesis method of furoimidazopyridine compound, crystal form of f...

Lumateperone bis-tosylate salts and crystals and methods for manufa...

Crystalline forms of N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-...

Methods for antagonizing a melanocortin 4 receptor

Salts of TAM inhibitors

Method for resolving optical isomer by using supercritical fluid ex...

Patents Applicationslast 30 patents

Process for Manufacturing Pibrentasvir Active Drug Substance

NOVEL FEAZD, NIAZD, AND CUAZD COMPLEXES INCORPORATING 1-(2-HYDROXYP...

CRYSTALLINE EPINEPHRINE MALONATE SALT

TEBIPENEM PIVOXIL CRYSTALLINE FORMS, COMPOSITIONS INCLUDING THE SAM...

NOVEL FEAZD, NIAZD, AND CUAZD COMPLEXES INCORPORATING 1-(2-HYDROXYP...

CRYSTALLINE FORMS OF A DEOXYCYTIDINE KINASE INHIBITOR AND USES THEREOF

CRYSTALLINE FORMS OF CFTR MODULATORS

SALTS OF AN FGFR INHIBITOR

CRYSTALLINE BIS-MIPROCIN FUMARATE

INHIBITORS OF APOL1 AND METHODS OF USING SAME

Injectable Suspensions

Blarcamesine co-crystals for the manufacture of pharmaceutical dosa...

CRYSTALLINE SALTS OF N-ETHYL-(5-FLUORO-1H-INDOL-3-YL)-N-METHYLETHAN...

PRODUCTION METHOD FOR AROMATIC HYDROXYCARBOXYLIC ACID CRYSTAL

CRYSTAL FORM OF BLARCAMESINE HYDROCHLORIDE, METHOD FOR PREPARING SA...

SALTS FOR MTOR COMPOUNDS

CRYSTALLINE SUBSTITUTED PYRAZINES AS PGI2 RECEPTOR AGONISTS

METHOD OF MANUFACTURING A SOLID FORM OF A BET BROMODOMAIN INHIBITOR

SALTS AND SOLID FORMS OF A COMPOUND THAT MODULATES IRAK4

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-...

CRYSTALLINE SALTS OR CO-CRYSTALS OF 2',6-DIFLUORO-5'-[3-(1-HYDROXY-...

CRYSTALLINE FORMS OF (6S,7S)-6-FLUORO-7-(2-FLUORO-5-METHYLPHENYL)-3...

POLYMORPHIC FORMS AND METHODS OF PRODUCING POLYMORPHIC FORMS OF A C...

COCRYSTALS OF NICOTINAMIDE RIBOSIDE SALTS, CRYSTALLINE FORMS, METHO...

PROCESS FOR PREPARING A BENZOATE SALT OF A 1-(3-AMINOPYRROLIDINE-1-...

COCRYSTAL

CRYSTALLINE FORMS OF A PAR4 INHIBITOR

ALUMINUM DIETHYLPHOSPHINATE CRYSTAL WITH LOW FINE POWDER CONTENT, P...

FXR (NR1H4) MODULATING COMPOUNDS

SOLID FORMS OF JAK INHIBITOR AND PROCESS OF PREPARING THE SAME